Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 4
1996 1
1997 3
1998 2
1999 3
2000 2
2003 1
2004 2
2006 2
2007 2
2008 4
2009 4
2010 11
2011 13
2012 10
2013 7
2014 10
2015 15
2016 14
2017 20
2018 25
2019 13
2020 13
2021 18
2022 23
2023 18
2024 35

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Platelet-Transfusion Thresholds in Neonates.
Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C, Deary A, Hodge R, Hopkins V, Lopez Santamaria B, Mora A, Llewelyn C, D'Amore A, Khan R, Onland W, Lopriore E, Fijnvandraat K, New H, Clarke P, Watts T; PlaNeT2 MATISSE Collaborators. Curley A, et al. Among authors: fijnvandraat k. N Engl J Med. 2019 Jan 17;380(3):242-251. doi: 10.1056/NEJMoa1807320. Epub 2018 Nov 2. N Engl J Med. 2019. PMID: 30387697 Clinical Trial.
[Haemophilia].
Loomans JI, Lock J, Peters M, Leebeek FW, Cnossen MH, Fijnvandraat K. Loomans JI, et al. Among authors: fijnvandraat k. Ned Tijdschr Geneeskd. 2014;158:A7357. Ned Tijdschr Geneeskd. 2014. PMID: 25351381 Review. Dutch.
Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial.
Pipe SW, Collins P, Dhalluin C, Kenet G, Schmitt C, Buri M, Jiménez-Yuste V, Peyvandi F, Young G, Oldenburg J, Mancuso ME, Kavakli K, Kiialainen A, Deb S, Niggli M, Chang T, Lehle M, Fijnvandraat K. Pipe SW, et al. Among authors: fijnvandraat k. Blood. 2024 Apr 4;143(14):1355-1364. doi: 10.1182/blood.2023021832. Blood. 2024. PMID: 38127586 Free PMC article. Clinical Trial.
The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH.
Makris M, Oldenburg J, Mauser-Bunschoten EP, Peerlinck K, Castaman G, Fijnvandraat K; subcommittee on Factor VIII, Factor IX and Rare Bleeding Disorders. Makris M, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2018 Dec;16(12):2530-2533. doi: 10.1111/jth.14315. Epub 2018 Nov 15. J Thromb Haemost. 2018. PMID: 30430726 Free article. No abstract available.
Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A.
Malec L, Peyvandi F, Chan AKC, Königs C, Zulfikar B, Yuan H, Simpson M, Álvarez Román MT, Carcao M, Staber JM, Dunn AL, Chou SC, d'Oiron R, Albisetti M, Demissie M, Santagostino E, Yarramaneni A, Wong N, Abad-Franch L, Gunawardena S, Fijnvandraat K; XTEND-Kids Trial Group. Malec L, et al. Among authors: fijnvandraat k. N Engl J Med. 2024 Jul 18;391(3):235-246. doi: 10.1056/NEJMoa2312611. N Engl J Med. 2024. PMID: 39018533 Clinical Trial.
International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology.
Rezende SM, Neumann I, Angchaisuksiri P, Awodu O, Boban A, Cuker A, Curtin JA, Fijnvandraat K, Gouw SC, Gualtierotti R, Makris M, Nahuelhual P, O'Connell N, Saxena R, Shima M, Wu R, Rosendaal FR. Rezende SM, et al. Among authors: fijnvandraat k. J Thromb Haemost. 2024 Sep;22(9):2629-2652. doi: 10.1016/j.jtha.2024.05.026. Epub 2024 Jun 20. J Thromb Haemost. 2024. PMID: 39043543 Free article. Review.
Neonatal thrombocytopenia: etiology, management and outcome.
Gunnink SF, Vlug R, Fijnvandraat K, van der Bom JG, Stanworth SJ, Lopriore E. Gunnink SF, et al. Among authors: fijnvandraat k. Expert Rev Hematol. 2014 Jun;7(3):387-95. doi: 10.1586/17474086.2014.902301. Epub 2014 Mar 25. Expert Rev Hematol. 2014. PMID: 24665958 Review.
Diagnosis and management of haemophilia.
Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Fijnvandraat K, et al. BMJ. 2012 May 2;344:e2707. doi: 10.1136/bmj.e2707. BMJ. 2012. PMID: 22551712 Free article. Review. No abstract available.
Inhibitors - genetic and environmental factors.
Lillicrap D, Fijnvandraat K, Santagostino E. Lillicrap D, et al. Among authors: fijnvandraat k. Haemophilia. 2014 May;20 Suppl 4:87-93. doi: 10.1111/hae.12412. Haemophilia. 2014. PMID: 24762282 Review.
242 results